Activation of the unfolded protein response in vitiligo: The missing link

Journal of Investigative Dermatology

Volumn 132, Issue 11, 2012, Pages 2502-2504

  Passeron, Thierry ^a   Ortonne, Jean Paul ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INFLAMMASOME; INTERLEUKIN 6; INTERLEUKIN 8; PHENOL DERIVATIVE;

CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOTHERAPY; MELANOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; UNFOLDED PROTEIN RESPONSE; UPREGULATION; VITILIGO;

EID: 84867786267     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.328     Document Type: Note

References (22)

1. Alkhateeb A, Fain PR, Thody A et al. (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-14 (Pubitemid 36597056)
2. Boissy RE, Liu YY, Medrano EE et al. (1991) Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long term cultures of melanocytes from vitiligo patients. J Invest Dermatol 97:395-404
3. Dell'Anna ML, Ottaviani M, Bellei B et al. (2010) Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. J Cell Physiol 223:187-93
4. Dell'anna ML, Picardo M (2006) A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res 19:406-11 (Pubitemid 44326402)
5. Goodman WA, Levine AD, Massari JV et al. (2009) IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183:3170-6
6. Grimes PE, Morris R, Avaniss-Aghajani E et al. (2004) Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51:52-61 (Pubitemid 38887475)
7. Harris JE, Harris TH, Weninger W et al. (2012) A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol 132:1869-79
8. Jin Y, Ferrara T, Gowan K et al. (2012) Nextgeneration DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol 132:1730-3
9. Kitamura R, Tsukamoto K, Harada K et al. (2004) Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol 202:463-75 (Pubitemid 38456165)
10. Klarquist J, Denman CJ, Hernandez C et al. (2010) Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res 23:276-86
11. Kotobuki Y, Tanemura A, Yang L et al. (2012) Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25:219-30
12. Kroll TM, Bommiasamy H, Boissy RE et al. (2005) 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cellmediated killing: relevance to vitiligo. J Invest Dermatol 124:798-806 (Pubitemid 40489508)
13. Lan CC, Ko YC, Tu HP et al. (2009) Association study between keratinocyte-derived growth factor gene polymorphisms and susceptibility to vitiligo vulgaris in a Taiwanese population: potential involvement of stem cell factor. Br J Dermatol 160:1180-7
14. Legros L, Cassuto JP, Ortonne JP (2005) Imatinib mesilate (Glivec): a systemic depigmenting agent for extensive vitiligo?. Br J Dermatol 153:691-2 (Pubitemid 41248249)
15. Lili Y, Yi W, Ji Y et al. (2012) Global activation of CD8(+) cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PloS one 7:e37513
16. Moretti S, Fabbri P, Baroni G et al. (2009) Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 24:849-57
17. Schallreuter KU, Moore J, Wood JM et al. (1999) In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 4:91-6 (Pubitemid 29491263)
18. Spritz RA (2012) Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol 132:268-73
19. Taher ZA, Lauzon G, Maguiness S et al. (2009) Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol 161:654-9
20. Toosi S, Orlow SJ, Manga P (2012) Vitiligoinducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol 132:2601-9
21. van den Boorn JG, Picavet DI, van Swieten PF et al. (2011) Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol 131:1240-51
22. Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J et al. (2011) Th17 cells and activated dendritic cells are increased in vitiligo lesions. PloS One 6:e18907